TW239861B - - Google Patents
Info
- Publication number
- TW239861B TW239861B TW082102440A TW82102440A TW239861B TW 239861 B TW239861 B TW 239861B TW 082102440 A TW082102440 A TW 082102440A TW 82102440 A TW82102440 A TW 82102440A TW 239861 B TW239861 B TW 239861B
- Authority
- TW
- Taiwan
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929206989A GB9206989D0 (en) | 1992-03-31 | 1992-03-31 | Chemical compounds |
| GB929217827A GB9217827D0 (en) | 1992-08-21 | 1992-08-21 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW239861B true TW239861B (cg-RX-API-DMAC10.html) | 1995-02-01 |
Family
ID=26300619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW082102440A TW239861B (cg-RX-API-DMAC10.html) | 1992-03-31 | 1993-04-01 |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN1081677A (cg-RX-API-DMAC10.html) |
| IL (1) | IL105232A0 (cg-RX-API-DMAC10.html) |
| MX (1) | MX9301837A (cg-RX-API-DMAC10.html) |
| TW (1) | TW239861B (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0303075A3 (en) * | 2000-08-07 | 2007-03-28 | Glaxosmithkline Lab Sas | Use of 5ht4 receptor antagonists in the manufacture of a medicament suitable for the prophylaxis or treatment of atrial fibrillation |
| WO2024067304A1 (zh) * | 2022-09-28 | 2024-04-04 | 瀚远医药有限公司 | 一种具有Sigma2和5HT2A抑制活性的化合物及用途 |
-
1993
- 1993-03-31 MX MX9301837A patent/MX9301837A/es unknown
- 1993-03-31 IL IL105232A patent/IL105232A0/xx unknown
- 1993-03-31 CN CN93105209A patent/CN1081677A/zh active Pending
- 1993-04-01 TW TW082102440A patent/TW239861B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| MX9301837A (es) | 1994-02-28 |
| IL105232A0 (en) | 1993-07-08 |
| CN1081677A (zh) | 1994-02-09 |